Clinical Research Innovation Meeting
Important Announcement
AACI is closely monitoring developments pertaining to the coronavirus outbreak. The safety and security of our meeting attendees, exhibitors, and cancer center patients is our top priority. At this time, there is no plan to cancel or postpone the 12th Annual AACI Clinical Research Innovation (CRI) Meeting, July 7-9, 2020.
Due to the evolving nature of this public health emergency, AACI is making the following amendments to registration deadlines for the meeting:
• Early-bird registration will be extended to Friday, May 15.
• Regular registration will be amended to May 16 through June 8.
• Late registration rates remain the same.
More information, including the program and registration, is available on the CRI meeting website. The website also highlights travel restrictions, public health recommendations, and cancellation policies related to COVID-19. Questions can be directed to Jaime Anderson at 412-647-3845.
Abstract Submissions
Abstract submissions are now closed and under review. Authors will be notified of abstracts selected for oral presentation in May. Any changes to this schedule will be communicated to abstract authors. Questions regarding abstracts can be directed to Kate Shaw at 412-645-1477.Last updated April 7, 2020
The 12th Annual AACI Clinical Research Innovation (CRI) Meeting will take place July 7-9, at Loews Chicago O'Hare Hotel in Rosemont, Illinois. The program will provide networking opportunities for AACI members, expanded poster sessions, and panel discussions with content experts. This year’s meeting theme is "Cancer Clinical Research: Focus on the Future."
Topics on the agenda include using technologies to improve cancer clinical trials, understanding how generational differences impact the clinical trials workforce, and enrolling patients in clinical trials across the lifespan. Last year's CRI annual meeting attracted more than 430 attendees to discuss a variety of issues related to the conduct of cancer clinical trials at academic cancer centers.